Report copyright - Novel targets, better treatments - Jefferies Group · summary up to w24” “Filgotinib: promising profile” “Inflammation market ~$65B by 2027” “$2.1B market with large unmet
Please pass captcha verification before submit form
Please pass captcha verification before submit form